WEBULL
News
KOD
27.96
+0.04%
0.01
Weekly Report: what happened at KOD last week (1222-1226)?
Weekly Report · 12/29/2025 10:06
Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday
Benzinga · 12/24/2025 16:06
U.S. RESEARCH ROUNDUP-APi Group, Elf Beauty, Tesla
Reuters · 12/23/2025 07:05
KODIAK SCIENCES INC <KOD.O>: JEFFERIES RAISES TARGET PRICE TO $39 FROM $24
Reuters · 12/23/2025 04:57
Weekly Report: what happened at KOD last week (1215-1219)?
Weekly Report · 12/22/2025 10:06
Friday's After-Hours Gainers: Biotech And Genomics Stocks Show Strength
NASDAQ · 12/22/2025 04:20
Major Insider Move Signals Bold Confidence in Kodiak Sciences Stock
TipRanks · 12/20/2025 02:05
Felix J. Baker, Director, Reports Acquisition of Kodiak Sciences Inc. Common Shares
Reuters · 12/19/2025 21:07
*Kodiak Sciences Announces Closing of $184M Public Offering of Common Stock >KOD
Dow Jones · 12/19/2025 02:08
Kodiak Sciences Raises Capital Through Completed Stock Offering
TipRanks · 12/18/2025 21:50
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Barchart · 12/18/2025 19:26
BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks
Reuters · 12/17/2025 15:40
Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday
Benzinga · 12/17/2025 15:07
BUZZ-Kodiak Sciences surges after boosted $160 mln equity raise
Reuters · 12/17/2025 14:45
BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse
Reuters · 12/17/2025 14:14
BUZZ-Kodiak Sciences dips after boosted $160 mln equity raise
Reuters · 12/17/2025 13:39
Kodiak Sciences 6.956M share Spot Secondary priced at $23.00
TipRanks · 12/17/2025 11:11
Kodiak Sciences prices upsized $160M stock offering at $23.00 per share
Seeking Alpha · 12/17/2025 07:45
*Kodiak Sciences Prices Upsized Underwritten Public Offering of 6.96M Shares at $23.00 Per Share>KOD
Dow Jones · 12/17/2025 04:02
*Kodiak Sciences: Offering Expected to Close on or About Dec. 18 >KOD
Dow Jones · 12/17/2025 04:02
More
Webull provides a variety of real-time KOD stock news. You can receive the latest news about Kodiak Sciences Inc. through multiple platforms. This information may help you make smarter investment decisions.
About KOD
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy and wet age-related macular degeneration. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate designed to inhibit interleukin-6 (IL-6)-mediated inflammation and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.